These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31828696)

  • 1. Gambling and Cannabis Use: Clinical and Policy Implications.
    Winters KC; Whelan JP
    J Gambl Stud; 2020 Mar; 36(1):223-241. PubMed ID: 31828696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary comparison of cannabis use in subsyndromal gamblers: select neurocognitive and behavioral differences based on use.
    Leppink E; Derbyshire K; Chamberlain SR; Grant JE
    J Addict Med; 2014; 8(6):443-9. PubMed ID: 25303983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weeding Out the Truth: Adolescents and Cannabis.
    Ammerman S; Tau G
    J Addict Med; 2016; 10(2):75-82. PubMed ID: 26985645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs and benefits of cannabis control policies
.
    Hall W
    Dialogues Clin Neurosci; 2020 Sep; 22(3):281-287. PubMed ID: 33162771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A "not-for-profit" regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand.
    Wilkins C
    Int J Drug Policy; 2018 Mar; 53():115-122. PubMed ID: 29346087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia.
    Lancaster K; Seear K; Ritter A
    Int J Drug Policy; 2017 Nov; 49():117-125. PubMed ID: 28886887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.
    Haney M; Evins AE
    Neuropsychopharmacology; 2016 Jan; 41(2):393-401. PubMed ID: 26286840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy.
    Melaragno JI; Bowman LJ; Park JM; Lourenco LM; Doligalski CT; Brady BL; Descourouez JL; Chandran MM; Nickels MW; Page RL
    Transplantation; 2021 Feb; 105(2):291-299. PubMed ID: 32413017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review.
    Volkow ND; Swanson JM; Evins AE; DeLisi LE; Meier MH; Gonzalez R; Bloomfield MA; Curran HV; Baler R
    JAMA Psychiatry; 2016 Mar; 73(3):292-7. PubMed ID: 26842658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetic modulation of alcohol/ethanol and cannabis exposure/co-exposure during different stages.
    Dobs YE; Ali MM
    Open Biol; 2019 Jan; 9(1):180115. PubMed ID: 30958117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations between delay discounting and low to moderate gambling, cannabis, and alcohol problems among university students.
    Stea JN; Hodgins DC; Lambert MJ
    Behav Processes; 2011 Nov; 88(3):202-5. PubMed ID: 21946096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing Motivations: Proactive Response Inhibition Toward Addiction-Related Stimuli in Quitting-Motivated Individuals.
    Brevers D; Bechara A; Kilts CD; Antoniali V; Bruylant A; Verbanck P; Kornreich C; Noël X
    J Gambl Stud; 2018 Sep; 34(3):785-806. PubMed ID: 29067545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis Use and Consequences.
    Mashhoon Y; Sagar KA; Gruber SA
    Pediatr Clin North Am; 2019 Dec; 66(6):1075-1086. PubMed ID: 31679598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of decision-making in cannabis-related problems among young adults.
    Gonzalez R; Schuster RM; Mermelstein RM; Diviak KR
    Drug Alcohol Depend; 2015 Sep; 154():214-21. PubMed ID: 26199058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned after three years of legalized, recreational marijuana: The Colorado experience.
    Ghosh TS; Vigil DI; Maffey A; Tolliver R; Van Dyke M; Kattari L; Krug H; Reed JK; Wolk L
    Prev Med; 2017 Nov; 104():4-6. PubMed ID: 28232101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological gambling and addiction to cannabis: common psychosocial profile?].
    Parolaa N; Boyer L; Simon N; Aghababian V; Lançon C
    Soins Psychiatr; 2014; (291):40-3. PubMed ID: 24741830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of data obtained from alcohol, cannabis, and gambling populations on Amazon's Mechanical Turk.
    Kim HS; Hodgins DC
    Psychol Addict Behav; 2017 Feb; 31(1):85-94. PubMed ID: 27893213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in cognition in young adult cannabis users.
    Becker MP; Collins PF; Schultz A; Urošević S; Schmaling B; Luciana M
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):529-543. PubMed ID: 29058519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.